Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 91.85
Bid: 91.70
Ask: 91.90
Change: 0.85 (0.93%)
Spread: 0.20 (0.218%)
Open: 91.10
High: 92.75
Low: 91.05
Prev. Close: 91.00
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Primary Healthcare Properties PLC

7 Feb 2019 15:21

RNS Number : 4201P
Capital International Limited
07 February 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Capital International Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Primary Health Properties PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

06/02/2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - MedicX Fund Ltd

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,239,673

0.16

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

1,239,673

0.16

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

07/02/2019

Contact name:

Paul Moran

Telephone number*:

01624 654226

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETUBAVRKWAURAR
Date   Source Headline
26th May 20203:15 pmRNSDirector/PDMR Shareholding
26th May 20203:15 pmRNSDirector/PDMR Shareholding
22nd May 202012:58 pmRNSTotal Voting Rights
18th May 20204:49 pmRNSApplication for listing re scrip dividend
12th May 20201:03 pmRNSHolding(s) in Company
11th May 20207:00 amRNSPortfolio Acquisition & Rental Collection Update
6th May 20202:30 pmRNSDirector/PDMR Shareholding
6th May 20202:20 pmRNSDirector/PDMR Shareholding
15th Apr 20207:00 amRNSCompletion of Developments
9th Apr 202012:34 pmRNSScrip Dividend reference price
7th Apr 20205:30 pmRNSDirector/PDMR Shareholding
7th Apr 20205:30 pmRNSDirector/PDMR Shareholding
1st Apr 20201:03 pmRNSAGM Voting
1st Apr 202012:54 pmRNSDirector Declaration
1st Apr 20207:00 amRNSTrading Update and Investor Q&A
30th Mar 20205:19 pmRNSHolding(s) in Company
27th Mar 20207:00 amRNSAnnual General Meeting - Update
26th Mar 20204:15 pmRNSHolding(s) in Company
24th Mar 202012:25 pmRNSDividend Declaration
16th Mar 20201:10 pmEQSHardman & Co Research: Q&A with Mike Foster on Primary Health Properties (PHP): Final results show accelerating rental growth
16th Mar 20207:00 amRNSRule 19.6(c) Confirmation
13th Mar 202011:00 amRNSDirector/PDMR Shareholding
13th Mar 202011:00 amRNSDirector/PDMR Shareholding
12th Mar 20207:00 amRNSForward funding acquisition of new PCC
6th Mar 20204:23 pmEQSEdison Investment Research Limited: Edison issues outlook on Primary Health Properties (PHP)
5th Mar 20203:00 pmRNSDirector/PDMR Shareholding
5th Mar 20203:00 pmRNSDirector/PDMR Shareholding
28th Feb 202010:35 amEQSHardman & Co Research: Primary Health Properties (PHP): Final results show accelerating rental growth
27th Feb 20209:24 amRNSAnnual Financial Report
26th Feb 202010:36 amRNSDirector/PDMR Shareholding
25th Feb 202012:00 pmRNSDirector/PDMR Shareholding
25th Feb 202012:00 pmRNSDirector/PDMR Shareholding
25th Feb 202012:00 pmRNSDirector/PDMR Shareholding
21st Feb 20204:57 pmRNSTotal Voting Rights
17th Feb 20203:02 pmRNSApplication for listing re scrip dividend
14th Feb 202010:47 amRNSDirector/PDMR Shareholding
12th Feb 20207:00 amRNSPreliminary Results
5th Feb 20204:00 pmRNSDirector/PDMR Shareholding
5th Feb 20204:00 pmRNSDirector/PDMR Shareholding
5th Feb 20207:00 amRNSForward Funding Acquisition
16th Jan 202011:14 amRNSScrip Dividend Reference Price
14th Jan 20207:00 amRNSNotice of Results
14th Jan 20207:00 amRNSDirectorate Change
8th Jan 20203:00 pmRNSDirector/PDMR Shareholding
8th Jan 20203:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20204:09 pmRNSDividend Declaration
17th Dec 20197:00 amRNSAcquisition and Forward Funding Acquisition
13th Dec 20195:00 pmRNSDirector/PDMR Shareholding
13th Dec 20195:00 pmRNSDirector/PDMR Shareholding
5th Dec 20195:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.